Jointly sponsored by Med Learning Group and Ultimate Medical Academy/CCM. This activity was co-provided by Amedco.
This activity is supported in part by an education grant from Lilly USA, LLC.
Release date: September 19, 2014
Valid through: September 19, 2015
Estimated Time to Complete Activity: 60 minutes
Physicians, Nurses and other medical professionals concerned with the concept of health numeracy, health literacy and effective patient communication.
This enduring, web-based activity is focused on the concept of health numeracy, health literacy and effective patient communication.
Upon completion of this activity, participants should be better able to:
Ruth Parker, MD
Professor of Medicine and Pediatrics
Michael Wolf, PhD
Professor of Medicine and Learning Sciences
Associate Division Chief of Research for General Internal Medicine
Kristine M. Gleason, MPH, RPh
Clinical Quality Leader
Department of Clinical Quality and Analytics
Northwestern Memorial Hospital
MLG Course Reviewer
Katherine Galluzzi, DO, CMD, FACOFP dist.
Professor and Chairperson, Department of Geriatrics
Philadelphia College of Osteopathic Medicine
Attending Physician, Family Medicine
Tenet Roborough Memorial Hospital
CCM/UMA Lead Nurse Planner
Margaret Governo, EdD, APRN BC
Staten Island, NY
Amedco Pharmacy Reviewer
Kristine Poloyac, RPh.
Critical Care Trauma Unit Based Clinical Pharmacist
UPMC Presbyterian Hospital
Pittsburgh, Pennsylvania 15213
Med Learning Group is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Med Learning Group designates this enduring activity for a maximum of 1.0 AMA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the live activity.
This enduring material activity, The Value of Health Literacy in Understanding and Achieving Goals in Clinical Practice (Treatment Minutes), has been reviewed and is acceptable for up to 1 Elective credit by the American Academy of Family Physicians. AAFP certification begins September 15, 2014. Term of approval is for one year from this date. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This program would be beneficial for nurses who work with patients with challenges in health literacy.
Ultimate Medical Academy/CCM is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation. Awarded 1.00 contact hour(s) of continuing nursing education of RNs and APNs.
Amedco is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. Successful completion of this program qualifies for up to 1.0 contact hours. Full attendance is required. No partial contact hours will be awarded for partial attendance.
Universal Activity Number (UAN): 0453-9999-14-087-H01-P (K)
In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Commercial Support, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in a MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.
Ms. Gleason has received royalties from her book publication, (published 2008): Medication Reconciliation—Practical Strategies and Tools for Joint Commission Compliance. Publisher: HC Pro. For ACPE purposes, the ACPE provider, Amedco, has determined that Ms. Gleason has no relevant financial relationship to disclose.
Dr. Parker has nothing to disclose.
Dr. Wolf has nothing to disclose.
MLG Course Reviewer - Dr. Galluzzi has nothing to disclose.
CCM/UMA Lead Nurse Planner - Margaret Governo, EdD, APRN BC has nothing to disclose.
Amedco Pharmacy Reviewer - Kristine Poloyac, RPh. has nothing to disclose.
The staff, planners and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME/CE activity:
Chris Drury, Medical Services for Med Learning Group has nothing to disclose.
Matthew Frese, General Manager of Med Learning Group has nothing to disclose.
Christina Gallo, SVP, Educational Development for Med Learning Group has nothing to disclose.
Melissa A Johnson, Program Manager for Med Learning Group has nothing to disclose.
Flavia Piazza, VP, Medical and Scientific Services for Med Learning Group has nothing to disclose.
Lauren Welch, VP, Accreditation and Outcomes, has nothing to disclose.
There are no fees for participating and receiving credit for this activity. During the accredited period, participants must read the learning objectives and faculty disclosures; study the educational activity; and complete the post-test and the evaluation form. If you pass the post-test and complete the evaluation your certificate will be available immediately for download in PDF format.
This site is best viewed with an HTML5 compatible browser, this list includes the versions of Mircrosoft Internet Explorer, Mozilla Firefox, Google Chrome, and Apple's Safari. You can visit the independent (3rd party) site www.whatismybrowser.com to determine if you have the latest version of your browser. Certain educational activities may require additional software to view multimedia, presentation, or printable versions of their content. That software may be: Adobe Flash, Apple Quicktime, Adobe Acrobat, Microsoft Powerpoint, Windows Media Player, and Real Networks Real One Player. Where such software is required it will be indicated.
Med Learning Group requires that faculty participating in any CME activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States.
During the course of this lectures, Drs Parker and Wolf, and Ms. Gleason may mention the use of medications for both FDA-approved and non-approved indications.
Please select type of credit: